Cargando…

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study

Background: Treatment of rheumatoid arthritis (RA)-related interstitial lung disease (ILD) is challenging, and many conventional and biologic disease-modifying anti-rheumatic drugs (DMARDs) have been associated with ILD development or progression. The aim of this multicentric retrospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassone, Giulia, Manfredi, Andreina, Atzeni, Fabiola, Venerito, Vincenzo, Vacchi, Caterina, Picerno, Valentina, Furini, Federica, Erre, Gian Luca, Tomietto, Paola, Fedele, Anna Laura, Della Casa, Giovanni, Nucera, Valeria, Giannitti, Chiara, Salvarani, Carlo, Sebastiani, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019755/ https://www.ncbi.nlm.nih.gov/pubmed/31963908 http://dx.doi.org/10.3390/jcm9010277

Ejemplares similares

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
por: Cassone, Giulia, et al.
Publicado: (2021)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
por: Vacchi, Caterina, et al.
Publicado: (2020)

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
por: Sebastiani, Marco, et al.
Publicado: (2023)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
por: Vacchi, Caterina, et al.
Publicado: (2020)

Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
por: Cassone, Giulia, et al.
Publicado: (2020)

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
por: MANFREDI, Andreina, et al.
Publicado: (2020)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
por: Cassone, Giulia, et al.
Publicado: (2020)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey
por: Sebastiani, Marco, et al.
Publicado: (2022)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
por: Sebastiani, Marco, et al.
Publicado: (2020)

Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device)
por: Manfredi, A., et al.
Publicado: (2019)

Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Personalized Medicine and Machine Learning: A Roadmap for the Future
por: Sebastiani, Marco, et al.
Publicado: (2022)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
por: Sebastiani, Marco, et al.
Publicado: (2021)

Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2020)

VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds
por: Pancaldi, Fabrizio, et al.
Publicado: (2022)

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
por: Nucera, Valeria, et al.
Publicado: (2021)

Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
por: Cacciapaglia, Fabio, et al.
Publicado: (2023)

Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma
por: Colaci, Michele, et al.
Publicado: (2014)

Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection
por: Cassone, Giulia, et al.
Publicado: (2013)

Lung complications of Sjogren syndrome
por: Luppi, Fabrizio, et al.
Publicado: (2020)

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
por: Erre, Gian Luca, et al.
Publicado: (2021)

Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature
por: Colaci, M., et al.
Publicado: (2015)

Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis
por: Dei, Giulia, et al.
Publicado: (2020)

Clinical and Serological Characteristics of a Monocentric Cohort of Patients Affected by Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Canofari, Claudia, et al.
Publicado: (2023)

Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies
por: Rodina, Yulia, et al.
Publicado: (2021)

Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
por: Tardella, Marika, et al.
Publicado: (2021)

A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung disease
por: Tardella, Marika, et al.
Publicado: (2022)

Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium”
por: Perniola, Simone, et al.
Publicado: (2023)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rsjeb4tnsle5rnhuhdjhm8t3t2